These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4393627)

  • 1. Reflections on the use of propranolol in angina pectoris.
    Mizgala HF; Khan AS; Davies RO
    Am Heart J; 1970 Sep; 80(3):428-30. PubMed ID: 4393627
    [No Abstract]   [Full Text] [Related]  

  • 2. Propranolol for Angina Pectoris.
    Manu P; Rogozea LM
    Am J Ther; 2016; 23(6):e1285-e1286. PubMed ID: 27828838
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the effects of propranolol and practolol on the exercise tolerance in angina pectoris.
    Coltart DJ; Hamer J
    Br J Pharmacol; 1970 Sep; 40(1):147P-148P. PubMed ID: 4395080
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the action of beta-adrenergic blockers in the treatment of angina pectoris].
    de Mey D
    Acta Cardiol; 1972; ():Suppl 15:255-6. PubMed ID: 4147609
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris.
    Hebb AR; Godwin TF; Gunn RW
    Can Med Assoc J; 1968 Feb; 98(5):246-51. PubMed ID: 4965821
    [No Abstract]   [Full Text] [Related]  

  • 7. -Receptor antagonists in angina pectoris.
    Prichard BN
    Ann Clin Res; 1971 Dec; 3(6):344-52. PubMed ID: 4400460
    [No Abstract]   [Full Text] [Related]  

  • 8. LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
    Ganeshan KP; Xavier KB
    Indian Heart J; 1972 Jun; 24():Suppl 1:197-20. PubMed ID: 4147275
    [No Abstract]   [Full Text] [Related]  

  • 9. [Propanolol in arterial hypertension. Beta-blockaders. Recent advances].
    Arauco R; Alagón A
    Prensa Med Mex; 1979; 44(5-6):97-104. PubMed ID: 45356
    [No Abstract]   [Full Text] [Related]  

  • 10. Reflections on the use of propranolol in angina pectoris.
    Dana JB
    J Maine Med Assoc; 1970 Oct; 61(10):241. PubMed ID: 5524780
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of the anti-angina effectiveness of nadolol and propranolol].
    Cremonesi A; Pagliarani PL; Guelfi P; Mattace R; Costa G; Bernardi G; Zacà F
    Boll Soc Ital Cardiol; 1979; 24(7):741-5. PubMed ID: 45306
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of adrenergic beta blocking agents in angina pectoris in a double blind trial].
    Saad EA; Prazeres PR; Siqueira PL; Amarante A; Levy S; Benchimol AB
    Arq Bras Cardiol; 1971 Feb; 24(1):7-16. PubMed ID: 4399358
    [No Abstract]   [Full Text] [Related]  

  • 13. On the psychopharmacology of beta adrenergic blockade.
    Greenblatt DJ; Shader RI
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):615-25. PubMed ID: 4404445
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
    Schaller K
    Z Arztl Fortbild (Jena); 1970 Jul; 64(13):671-3. PubMed ID: 4398819
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.
    Turner GG; Nelson RR; Nordstrom LA; Diefenthal HC; Gobel FL
    Br Heart J; 1978 Dec; 40(12):1361-70. PubMed ID: 32899
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity.
    Frishman W; Kostis J; Strom J; Hossler M; Elkayam U; Goldner S; Silverman R; Davis R; Weinstein J; Sonnenblick E
    Am Heart J; 1979 Oct; 98(4):526-35. PubMed ID: 39447
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenergic blockade in some cardiovascular diseases.
    Tarazi RC
    Cardiovasc Clin; 1975; 7(1):173-85. PubMed ID: 238741
    [No Abstract]   [Full Text] [Related]  

  • 20. Propranolol in angina pectoris.
    Billimoria AR; Haveliwala HK; Vohra JK; Shah SJ
    Indian Heart J; 1972 Jan; 24(1):20-4. PubMed ID: 5071330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.